Contributions of Department of Biotechnology to non-communicable disease biology research in India

被引:0
|
作者
Shenoy, Sandhya R. [1 ]
机构
[1] Dept Biotechnol, Med Biotechnol Div, Human Genom & Oncol Unit, Block 2,CGO Complex,Lodi Rd, New Delhi 110003, India
来源
CURRENT SCIENCE | 2022年 / 123卷 / 02期
基金
英国医学研究理事会;
关键词
Bio-banks; cohort study; funding agency; non-communicable diseases; partnership centres;
D O I
10.18520/cs/v123/i2/148-153
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The last two decades have seen a shift of focus from communicable to non-communicable diseases (NCDs). NCDs, including cancer, diabetes, cardiovascular diseases, chronic lung disease, chronic kidney disease, neurological disorders, etc., pose devastating health consequences for individuals, families and communities, and threaten health systems. The socio-economic costs associated with these chronic diseases make their control a global priority. The Department of Biotechnology is working to provide leadership and evidence-based actions on surveillance, prevention and control of NCDs to reduce the disease burden. The Department of Biotechnology (DBT) aims to develop and support competitive research and development (R&D) programmes and generate new programmes from basic to clinical and transla-tional research under NCD conditions. Diseases addressed in the programme include but are not limited to cancer, diabetes, hypertension, cardiovascular diseases, lung diseases, kidney disorders, autoimmune disorders, eye diseases, osteoporosis and bone biology, diseases of the gastrointestinal system, neurological disorders, etc. This article summarizes the contributions of DBT to NCD biology research in India through finan-cial support.
引用
收藏
页码:148 / 153
页数:6
相关论文
共 50 条
  • [41] Pakistan recognises burden of non-communicable disease
    Ahmed, K
    LANCET, 2004, 363 (9422): : 1708 - 1708
  • [42] Positive medicine to prevent non-communicable disease
    Climie, Rachel E.
    Empana, Jean-Philippe
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2025,
  • [43] Democracy and implementation of non-communicable disease policies
    Allen, Luke N.
    Goiana-da-Silva, Francisco
    Nicholson, Brian D.
    LANCET GLOBAL HEALTH, 2020, 8 (04): : E484 - E484
  • [44] Financing national non-communicable disease responses
    Allen, Luke Nelson
    GLOBAL HEALTH ACTION, 2017, 10
  • [45] Gout is a neglected non-communicable disease in the Pacific
    Goarant, Cyrille
    Acharya, Shrish
    LANCET GLOBAL HEALTH, 2024, 12 (04): : e550 - e551
  • [46] Understanding dental caries as a non-communicable disease
    Nigel B. Pitts
    Svante Twetman
    Julian Fisher
    Philip D. Marsh
    British Dental Journal, 2021, 231 : 749 - 753
  • [47] Diabetes and the global burden of non-communicable disease
    Matthews, DR
    Pramming, S
    LANCET, 2003, 362 (9397): : 1763 - 1764
  • [48] Silent threat: Non-communicable disease and obesity
    Ratzan, SC
    JOURNAL OF HEALTH COMMUNICATION, 2004, 9 (01) : 1 - 2
  • [49] Principles for the prevention and control of non-communicable disease
    Sailesh Mohan
    Kamlesh Khunti
    Dorairaj Prabhakaran
    Nature Medicine, 2023, 29 : 1598 - 1600
  • [50] Parsimony for Non-Communicable Disease Prevention: A Checklist
    Ratzan, Scott C.
    JOURNAL OF HEALTH COMMUNICATION, 2011, 16 (05) : 455 - 457